Find Utreloxastat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1213269-96-5, Utreloxastat [inn], Ww8kzk2pzt, Ptc857, Ptc-857, 2,5-cyclohexadiene-1,4-dione, 2,3,5-trimethyl-6-nonyl-
Molecular Formula
C18H28O2
Molecular Weight
276.4  g/mol
InChI Key
IJWAQTHZBDBIID-UHFFFAOYSA-N
FDA UNII
WW8KZK2PZT

Utreloxastat
UTRELOXASTAT is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.
1 2D Structure

Utreloxastat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
2.1.2 InChI
InChI=1S/C18H28O2/c1-5-6-7-8-9-10-11-12-16-15(4)17(19)13(2)14(3)18(16)20/h5-12H2,1-4H3
2.1.3 InChI Key
IJWAQTHZBDBIID-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
WW8KZK2PZT
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1213269-96-5

2. Utreloxastat [inn]

3. Ww8kzk2pzt

4. Ptc857

5. Ptc-857

6. 2,5-cyclohexadiene-1,4-dione, 2,3,5-trimethyl-6-nonyl-

7. Unii-ww8kzk2pzt

8. 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione

9. Compound C9 [wo2020081879a2]

10. Compound C9 (wo2020081879a2)

11. Utreloxastat [usan]

12. Schembl1713853

13. Utreloxastat (jan/usan/inn)

14. Chembl5314565

15. Gtpl13260

16. Da-58934

17. Ms-23936

18. Hy-132845

19. Cs-0204152

20. D12510

21. G18378

2.4 Create Date
2010-07-06
3 Chemical and Physical Properties
Molecular Weight 276.4 g/mol
Molecular Formula C18H28O2
XLogP35.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count8
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area34.1
Heavy Atom Count20
Formal Charge0
Complexity438
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty